Updated from 4:13 p.m. ET
Shares of medical-equipment makers Varian Medical Systems (VAR) and Hologic ( HOLX) fell Thursday after their competitor, Intuitive Surgical (ISRG) announced weaker-than-expected fourth-quarter sales as hospitals cut spending on new equipment.
Late Wednesday, Sunnyvale, Calif.-based Intuitive said fourth-quarter sales rose 22%, but the figure still fell short of Wall Street expectations. The company cited a weak economy as the culprit in lower-than-expected surgical device sales.
Intuitive closed down $7.34 or 6.2% to $110.54 after the shares fell to a low of $99.75 during the session, their lowest point in nearly two years.
"This reaffirms our view that hospital capital equipment spending materially deteriorated in the fourth and that 2009 capital expenditure budgets will continue to face pressure," said Citi analyst Amit Bhalla, in a note to investors.Palo Alto, Calif.-based Varian and Bedford, Mass.-based Hologic both make different products, but also count hospitals as key customers. With the economy lagging, hospitals and other health care providers have been cutting costs and spending, which includes buying less new equipment. Shares of Hologic, which makes diagnostic and imaging systems geared toward women's health, fell 71 cents, or 5.9%, to $11.43 for the day. The stock has traded between $10.54 and $35.79 over the last 52 weeks. Meanwhile, shares of Varian, which makes radiation therapy systems, fell $1.62, or 4.7%, to $32.42 in midday trading. The stock reached a low of $30.04 earlier in the session, its lowest point in more than five years. Bhalla said the lagging economy is likely to hurt sales of Hologic's digital mammography systems, but reaffirmed a "Buy" rating. He reaffirmed a "Hold" rating on Varian, citing likely weakness in new orders.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV